• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    8.57 Down 0.35(3.92%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:8.92
    Open:8.85
    Bid:8.57 x 100
    Ask:8.87 x 1000
    1y Target Est:10.38
    Beta:1.12
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.38 - 8.89
    52wk Range:3.34 - 9.83
    Volume:10,859,677
    Avg Vol (3m):5,266,560
    Market Cap:2.05B
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 3.92%2.05B
    MRKDown 0.41%165.58B
    NVSDown 1.01%237.61B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):69.48
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.44
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback